Market Research Report: MetOx International, Inc.
Company Overview
Name: MetOx International, Inc.
Mission: Our purpose is to deliver the world’s most advanced and efficient wire - enabling clean, reliable, and abundant power for humanity.
Founded: No information is available
Founders:
- Alex Ignatiev, PhD. (Co-founder, Advisor)
- James Carr (Chief Financial & Corporate Strategy Officer)
Key People:
- Bud Vos (Chief Executive Officer)
- James Carr (Chief Financial & Corporate Strategy Officer)
- Mark Kennard, PhD. (Chief Technology Officer)
- Jay Vitha (VP of Business Development)
- Jim Mallinak (SVP of Operations)
- Alison Brock (Sr. Director of Human Resources)
- Alex Ignatiev, PhD. (Co-founder, Advisor)
- Vladimir Matias, PhD. (Technical Advisor)
- Venkat Selvamanickam, PhD. (Technical Advisor)
- W. Jim Jewitt (Advisor)
Headquarters: 11331 Tanner Road, Houston, TX, 77041, USA
Number of Employees: No information is available
Revenue: No information is available
Company Specialty: MetOx is known for manufacturing high-temperature superconducting (HTS) wire, specifically their proprietary Xeus™ wire technology, which is critical for clean energy generation and efficient power delivery.
Products
Products Offered:
1. Xeus™ Wire:
- High-Level Description: Xeus™ wire is an advanced high-temperature superconducting wire manufactured using a proprietary production process to deliver high power at low voltage with essentially no loss.
- Key Features:
- Operates at much higher temperatures compared to low temperature superconducting wire (LTS).
- Produces stronger magnetic fields.
- Facilitates high current-carrying capacity.
- Eliminates electrical resistance.
- Maintains high performance under high magnetic fields.
- Manufactured using advanced MOCVD processes in continuous reel-to-reel production.
Recent Developments
Recent Developments:
1. Series B Capital Infusion (December 12, 2023):
- MetOx received a strategic capital infusion led by Koch Disruptive Technologies (KDT) to increase production capacity of Xeus™ HTS wire.
- [Read More](https://metoxtech.com/series-b-capital-infusion)
2. New Chief Financial and Corporate Strategy Officer (October 12, 2023):
- James Carr joined MetOx, bringing expertise in corporate strategy and climate tech startups, to aid in the company’s scaling efforts.
- [Read More](https://metoxtech.com/james-carr-joins-metox)
3. Innovation Funding (October 5, 2023):
- MetOx awarded $3 million in innovation funding from the U.S. Department of Energy (DOE) ARPA-E to advance HTS wire manufacturing.
- [Read More](https://metoxtech.com/innovation-funding)
4. Collaboration Agreement (August 17, 2023):
- MetOx entered a strategic collaboration with Empyrean, and MagCorp to scale up a new cancer treatment radiotherapy system.
- [Read More](https://metoxtech.com/collaboration-agreement)
5. New CEO Appointment (August 9, 2022):
- Arthur (Bud) Vos appointed as the Chief Executive Officer, bringing experience in scaling start-ups.
- [Read More](https://metoxtech.com/new-ceo-appointment)
New Product Launches:
- No specific new products launched information available.
New Features Added:
- No specific new features added information available.
New Partnerships:
- Empyrean and MagCorp for developing new radiotherapy systems.
Conclusion
MetOx International, Inc. specializes in the development and production of high-temperature superconducting wire, specifically their Xeus™ wire, which plays a crucial role in enabling efficient and clean energy generation and delivery. The company has made significant strides in scaling up their manufacturing capabilities and has formed strategic collaborations to further its impact on the energy and medical technology sectors. Recent strategic capital infusions and innovation funding demonstrate strong growth and commitment to advancing HTS wire technology. For further details, please visit their official [website](https://metoxtech.com).
©2024 MetOx International, Inc.